Evaluating the Infectivity, Safety, and Immunogenicity of a Respiratory Syncytial Virus Vaccine (RSV 6120/∆NS2/1030s) in RSV-Seropositive Children and RSV-Seronegative Infants and Children
Clinical trial NCT03387137 · COMPLETED
Trial details
- NCT number
- NCT03387137
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-13
- Primary completion
- 2019-11-22
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.